Mortality and pre‐hospitalization use of low‐dose aspirin in COVID‐19 patients with coronary artery disease

To determine whether pre‐hospitalization use of aspirin is associated with all‐cause mortality in coronavirus disease 2019 (COVID‐19) patients with coronary artery disease (CAD). We recruited 183 adult patients with CAD diagnosed with COVID‐19, including 52 taking low‐dose aspirin (mean [SD] age, 69...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Shuai, Chen, Peng, Li, Huaping, Chen, Chen, Wang, Feng, Wang, Dao Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812246/
https://www.ncbi.nlm.nih.gov/pubmed/33336936
http://dx.doi.org/10.1111/jcmm.16198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812246/
https://www.ncbi.nlm.nih.gov/pubmed/33336936
http://dx.doi.org/10.1111/jcmm.16198

Ejemplares similares